Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
PMCID: PMC8275860
Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
doi: 10.3389/fendo.2014.00140 25 LiYDuffyKBOttingerMARayBBaileyJAHollowayHWet al
This part of the guideline is silly because there is no way to risk stratify these patients using the stated risk factors
US$ 21.62
US$ 25.29
US$ 25.19
